Jonathan Allan - 01 Dec 2024 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)

Role: GENERAL COUNSEL & CORP SEC
Signature: /s/ Jonathan Allan
Issuer symbol: STOK
Transactions as of: 01 Dec 2024
Net transactions value: $0
Form type: 4
Filing time: 03 Dec 2024, 16:14:20 UTC
Previous filing: 22 May 2024
Next filing: 05 Dec 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	STOK	Common Stock	Options Exercise	$0	+33,927	+691%	$0.000000	38,838	01 Dec 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	STOK	Restricted Stock Unit (RSU)	Options Exercise	$0	-33,927	-73%	$0.000000	12,357	01 Dec 2024	Common Stock	33,927		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported total includes an aggregate 2,313 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan in one or more transactions exempt pursuant to Rules 16b-3(c) and 16b-3(d).
F2	Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
F3	33,927 restricted stock units vest on December 1, 2024 and 12,357 will vest on December 1, 2025, subject to the reporting person's continued service to the Issuer on each such date.